TG Therapeutics, Inc. (NASDAQ:TGTX) shareholders have seen the share price descend 16% over the month. But that isn't a problem when you consider how the share price has soared over the last year.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, if you buy shares in a high quality company at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback